What is the last grey market premium of Influx Healthtech IPO?
Listing Review: Will update on listing.
Subscription status of Influx Healthtech IPO
Influx Healthtech IPO Price Rs. 96 Lot 1200 shares, Rs.58.57 Crore |
||||
QIB | NII x | RII x | Total x | Applications |
Note: |
Influx Healthtech IPO Allotment Link:
What is the business of Influx Healthtech?
Influx Healthtech IPO Details
Sector: Healthcare |
|
IPO opens on | 18 June 2025 |
IPO closes on | 20 June 2025 |
Issue Type | Book Built Issue IPO |
Issue Size | 6100,800 Shares / Rs 58.57 Crore |
* Fresh Issue | 5000,400 Shares / Rs 48.00 Crore |
* Offer for Sale – | 1100,400 Shares/ Rs. 10.56 Crore |
Market Maker Portion | 306,000 Shares |
Net offer to Public | 5794,800 Shares Rs.55.63 Crores |
Face Value per share | Rs. 10 |
Price Band | Rs. 91-96 |
Employee discount | Rs. 0 per share |
Retail Lot Size | 1200 Shares |
Listing will at | NSE SME |
Shares offered in IPO |
||
Shares | Rs. (Crore) | |
QIB (50%) | 2897400 | 27.82 |
HNI (15%) | 869220 | 8.34 |
RII (35%) | 2028180 | 19.47 |
Total Shares | 5794800 | 55.63 |
Retail portion will be oversubscribed by |
1690 | |
Forms | ||
How much Shares to Apply in this IPO? | ||
Min Retail Application | 1200 Shares | Rs.115200 |
Min HNI Application | 2400 Shares | Rs.230400 |
Who are the Promoters of Influx Healthtech?
The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.
What are the Objects of Influx Healthtech IPO?
a) Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division Rs. 22.60 crores
b) Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division Rs. 11.59 Crores
c) Purchase of Machineries for Homecare and Cosmetic Division Rs. 2.76 Crore
d) General corporate purposes
Tentative timetable |
|
IPO opens on | 18 June 2025 |
IPO Closes on | 20 June 2025 |
IPO Allotment on | 23 June 2025 |
Refund Initiation | 24 June 2025 |
Credit of Shares | 24 June 2025 |
Listing on | 25 June 2025 |
Registered Office of the Company Influx Healthtech Limited 109, Ghanshyam Enclave Premises Co-op Soc Plot No. 856, Laljipada Kandivali West, Mumbai, Maharashtra |
The Lead Manager of this IPO Rarever Financial Advisors Pvt ltd |
Who is the Registrar to IPO? Maashitla Securities Pvt ltd |
Influx Healthtech IPO GMP grey market premium, review, Subscription, allotment, listing estimate
Influx Healthtech Financials
Period Ended | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
Assets | 70.3 | 41.1 | 28.3 |
Revenue | 104.99 | 100.1 | 76.07 |
Profit After Tax | 13.37 | 11.22 | 7.2 |
Net Worth | 36.15 | 22.87 | 11.65 |
Reserves and Surplus | 18 | 22.85 | 11.63 |
Total Borrowing | 0.22 | 0.32 | 0.8 |
Amount in Rs. Crore |
Performance Indicators
KPI | Values |
ROE | 36.98% |
ROCE | 49.17% |
Debt/Equity | 0.01 |
RoNW | 36.98% |
PAT Margin | 12.75 |
Price to Book Value | 7.62 |
EPS Rs. | 7.36 |
PE Ratio | 13.04 |
How Influx Healthtech IPO compares with the Peers?
Company Name | P/E (x) | P/BV Ratio |
Sudarshan Pharma Industries Ltd | 48.28 | 6.2 |
Quest Laboratories Limited | 10.38 | 1.73 |
Influx Healthtech | 13.04 | 7.62 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Influx Healthtech IPO Review by Paresh Gordhandas, CA & Research Analyst.
+ from grey market angle:
Quicklinks